Helvea

Type: Company
Name: Helvea
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

AstraZeneca shores up defences against Pfizer

AstraZeneca has been making a series of big deals over the past three months as it looks to close the door once and for all on any Pfizer merger.AZ rebuffed Pfizer’s $118 billion offer for the firm in May for being too low, and its chief executive Pascal ... [Published Pharmafocus - Aug 22 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Geneva Banks Break 200-Year Silence to Unveil Earnings

Switzerland ’s two largest closelyheld banks are poised to publish their earnings after twocenturies of secrecy.Cie. Lombard, Odier SCA, the Geneva-based bank establishedin 1796, is due to publish its financial statement on Aug. 28,according to a company ... [Published Bloomberg - Aug 22 2014]
Entities: Switzerland, Bank, Geneva
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

AZ may be too expensive for Pfizer, Orexo to up reliance on partners, Santhera raises cash

Welcome to the latest edition of our weekly EuroBiotech Report . AstraZeneca ( $AZN ) continued to make progress with its pipeline this week, with the antibiotic it is developing with Actavis' ( $ACT ) Forest Laboratories the latest to impress in clinical ... [Published FierceBiotech - Aug 21 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 4 reports

Pfizer reportedly looks at possible Actavis bid whilst weighing next steps over AstraZeneca

According to people close to the matter, Pfizer is looking at other possible acquisition targets, including Actavis, as it mulls whether or not to continue with its efforts to buy AstraZeneca. The sources indicated that AstraZeneca, which rebuffed Pfizer's ... [Published FirstWord Pharma - Aug 21 2014]
First reported Aug 12 2014 - Updated Aug 13 2014 - 3 reports

Galenica stocks jump on business split plan

Galenica shares jumped yesterday after the company said it planned to list its two main arms separately as soon as 2017, fuelling speculation that the drug unit could be picked up in a takeover.ReutersZurichShares in Swiss pharmacies operator and drugs ... [Published Gulf Times - Aug 12 2014]
Entities: Galenica AG, Takeover, Drugs
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

OMV profit drops in Q2 as Libya crisis lifts costs

Austrian oil and gas group OMV’s underlying operating profit halved in the second quarter as the continuing crisis in Libya forced it to raise production in higher-cost countries.OMV, which is investing heavily in new exploration projects to cut reliance ... [Published Gulf Times - Aug 12 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Swiss solar supplier Meyer Burger's net loss widens

* Net loss widens to 88 million Sfr * Analysts had forecast net loss of 51 mln Sfr * New orders rise 90 pct to 157 mln Sfr ZURICH, Aug 12 (Reuters) - Swiss solar industry supplier Meyer Burger posted a bigger-than-expected net loss in the first half of ... [Published Sharenet - Aug 12 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

AstraZeneca plc’s Hold Rating Reaffirmed at Panmure Gordon (AZN)

AstraZeneca plc (LON:AZN)A number of other firms have also recently commented on AZN. Analysts at Deutsche Bank reiterated a "hold" rating on shares of AstraZeneca plc in a research note on Thursday. They now have a GBX 3,950 ($67.50) price target on ... [Published American Banking News - Jul 25 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 3 reports

Roche's breast cancer franchise keeps delivering, with huge jumps for Perjeta, Kadcyla

Blame a strong Swiss franc on any falling sales and profits Roche ($RHHBY) put up in the first half of 2014, the company said Thursday. The Swiss pharma's cancer drugs certainly didn't cause the decline, with newcomers Perjeta and Kadcyla helping power ... [Published FiercePharma - Jul 24 2014]
First reported Jul 22 2014 - Updated Jul 23 2014 - 1 reports

Credit Suisse quits commodities trading, cuts $8B from risk-weighted assets

14:13 ET | About: Credit Suisse Group AG (CS)Credit Suisse (CS -1.7%) says it will quit commodities trading after chalking up its biggest loss since the financial crisis in 2008, the result of a 1.6B Swiss franc ($1.78B) fine from U.S. authorities for ... [Published Seeking Alpha - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

UPDATE 2-Actelion CEO seeks to diffuse takeover talk

* Actelion rumoured as tax-driven takeover target* CEO says shareholders support its independence* Company raises full-year outlook* Q2 core earnings 233 mln Sfr vs 171 mln forecast* Shares rise 2.4 pct, outperform sector (Adds CEO quotes, details on ... [Published Reuters - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

AstraZeneca plc Given Hold Rating at Helvea (AZN)

AstraZeneca plc (LON:AZN)Other equities research analysts have also recently issued reports about the stock. Analysts at Citigroup Inc. reiterated a "buy" rating on shares of AstraZeneca plc in a research note on Wednesday, July 16th. They now have a ... [Published American Banking News - Jul 22 2014]

Quotes

"Astra will ask for much more, and they have proven they are building a very solid pipeline," Helvea analyst Odile Rundquist told Bloomberg . "My impression is that the deal will never go through, because it is too expensive for Pfizer." Other analysts have suggested GlaxoSmithKline GSK ) as an alternative target, but even after its recent share price drop its market cap is near £70 billion...
...week," despite AstraZeneca's stock climbing more than 7 percent over the past few days on speculation of renewed takeover interest from Pfizer. "I know the stock is rallying on anticipation but I suspect if anything is going to happen it is more likely to happen in November or December" Mahony added
"We had a good first half, driven mainly by our cancer medicines, especially the new breast cancer medicines, Perjeta and Kadcyla" CEO Severin Schwan said in a statement

More Content

All (23) | News (21) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Pfizer could try to acquire Actavis as back-up ... [Published Pharma Letter - Aug 22 2014]
AstraZeneca shores up defences against Pfizer [Published Pharmafocus - Aug 22 2014]
Geneva Banks Break 200-Year Silence to Unveil E... [Published Bloomberg - Aug 22 2014]
AZ may be too expensive for Pfizer, Orexo to up... [Published FierceBiotech - Aug 21 2014]
Pfizer reportedly looks at possible Actavis bid... [Published FirstWord Pharma - Aug 21 2014]
Pfizer eyes Actavis in backup plan to another A... [Published FiercePharma - Aug 21 2014]
AstraZeneca share price: Drugmaker unveils part... [Published Invezz - Aug 21 2014]
AstraZeneca Is Tougher Pfizer Target as Possibl... [Published Washington Post - Aug 21 2014]
OMV profit drops in Q2 as Libya crisis lifts costs [Published Gulf Times - Aug 12 2014]
Galenica stocks jump on business split plan [Published Gulf Times - Aug 12 2014]
Galenica's business split fuels speculation of ... [Published Yahoo! UK and Ireland - Aug 12 2014]
Galenica Prepares to Split in Two as CEO Ebswor... [Published Washington Post - Aug 12 2014]
Swiss solar supplier Meyer Burger's net loss wi... [Published Sharenet - Aug 12 2014]
AstraZeneca plc’s Hold Rating Reaffirmed at Pan... [Published American Banking News - Jul 25 2014]
Roche's breast cancer franchise keeps deliverin... [Published FiercePharma - Jul 24 2014]
Roche Profit Falls on Franc Strength as New-Dru... [Published Washington Post - Jul 24 2014]
Roche Profit Falls on Franc Strength as New-Dru... [Published Washington Post - Jul 24 2014]
Credit Suisse quits commodities trading, cuts $... [Published Seeking Alpha - Jul 22 2014]
AstraZeneca plc Given Hold Rating at Helvea (AZN) [Published American Banking News - Jul 22 2014]
UPDATE 2-Actelion CEO seeks to diffuse takeover... [Published Reuters - Jul 22 2014]
Goodbye Biotech "Growth Bubble"; Hello Pharma "... [Published Zero Hedge - Apr 22 2014]
EUROPEAN EQUITY OPENING HEADLINES INCLUDING: Po... [Published Proactiveinvestors United Kingdom RSS feed - Apr 09 2014]
800 jobs being cut at Zurich as insurer moves t... [Published Financial Post | Business » Executive - Mar 11 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Goodbye Biotech "Growth Bubble"; Hello Pharma "... [Published Zero Hedge - Apr 22 2014]
While the rest of the market has been largely quiet as earnings week unfolds, it have been the pharma companies that has stolen the spotlight in the past few days. First it was the rumor that Pfizer may, reluctantly, be courting Astra-Zeneca, then yesterday ...
800 jobs being cut at Zurich as insurer moves t... [Published Financial Post | Business » Executive - Mar 11 2014]
Zurich Insurance Group AG, the biggest Swiss insurer, plans to save $250 million annually by cutting as many as 800 jobs after lowering its profit goal in December, the company said. Zurich plans to remove management layers between the headquarters ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.